INDOCO — INDOCO REMEDIES Balance Sheet
0.000.00%
- IN₹26.16bn
- IN₹35.85bn
- IN₹16.65bn
- 56
- 16
- 27
- 21
Annual balance sheet for INDOCO REMEDIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 87.9 | 168 | 119 | 221 | 204 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,381 | 3,228 | 4,418 | 5,283 | 3,741 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,225 | 7,736 | 8,136 | 9,547 | 10,013 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,535 | 5,847 | 6,676 | 8,911 | 11,252 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 13,151 | 14,861 | 16,582 | 21,447 | 24,299 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,069 | 4,249 | 4,245 | 6,123 | 8,080 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,461 | 5,815 | 6,299 | 10,348 | 14,079 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 7,690 | 9,046 | 10,283 | 11,099 | 10,220 |
Total Liabilities & Shareholders' Equity | 13,151 | 14,861 | 16,582 | 21,447 | 24,299 |
Total Common Shares Outstanding |